
Vantage Point Global, Corp. is a private holding company — a steward of long-horizon capital with equity interests in independently licensed businesses across life sciences, agricultural technology, and novel therapeutic delivery. We do not operate. We steward. Each portfolio company is its own legal entity, holding its own licenses, employing its own people, and bearing its own regulatory obligations. We provide patient capital, board-level governance, and principled long-term ownership. Headquartered in Texas.
We are stewards of patient capital — not operators. We take carefully considered equity positions in independently licensed and governed businesses, and we hold them with discipline and purpose. We do not manage, direct, or control. We govern at the board level, support with strategic insight, and trust each portfolio company's own leadership to execute.
Equity stewardship in independently licensed therapeutic and botanical businesses — each operating under its own regulatory framework, compliance infrastructure, and management team
Long-horizon positions in novel delivery platforms with independently developed IP and their own commercialization leadership — we hold, we don't direct
Patient equity in independently certified cultivation businesses, each holding its own export licenses, quality certifications, and government authorizations
Board-level participation and strategic counsel — never operational control, never day-to-day management, never assumption of regulatory responsibility.
Three independently licensed and operated companies. One patient holding strategy.

An independently licensed, EU-GACP audited cultivation and export company in Costa Rica. Hybrida Farms holds its own government licenses, employs its own team, and conducts its own regulated export operations. 16+ hectares of controlled-environment greenhouse infrastructure. Exporting internationally since March 2026.

Vantage Point Global Labs
An independently licensed GMP manufacturing company in El Guarco, Costa Rica, holding its own Ministry of Health authorization (August 2026). The company independently produces pharmaceutical-grade extracts, formulations, and finished products for regulated export to Germany, Switzerland, the UK, and the EU.

SipIT Technologies
An independently developed proprietary active-ingredient delivery platform with its own IP, management, and commercialization strategy. Applications span pharmaceutical, nutraceutical, and consumer health sectors.
Where durable value is built.
We seek businesses where regulatory complexity, licensing requirements, and compliance infrastructure create barriers to entry that protect long-term equity value. We do not seek operational control. We seek well-governed, independently managed companies where our capital and board participation accelerate outcomes.
We participate at the board level and provide strategic guidance. Day-to-day operations, employment, and regulatory compliance are the independent responsibility of each portfolio company.
We hold equity in platforms with rigorous methodology, defensible IP, and real-world clinical or commercial applicability — independently validated by each company's own scientific teams.
We size positions for the full regulatory and commercial cycle. Our holding horizon is long enough to see licensed value fully realized without forcing premature exits.
We hold equity in the future of life sciences, therapeutic delivery, and regulated agriculture… stewarded responsibly, one independently licensed company at a time.
Independently licensed companies across two jurisdictions. Commercializing into four regulated global markets.
Costa Rica & Texas, USA
EU, LATAM, APAC, United States
Independently certified cultivation infrastructure
Hybrida Farms · VP Global Labs · SipIT Technologies
To portfolio company by Costa Rica Ministry of Health
Completed independently by Hybrida Farms
Each portfolio company is an independent enity & holds its own licenses, employs its own personnel, and bears its own regulatory obligations. Vantage Point Global, Corp. holds equity interests and participates in governance, it does not conduct, direct, or control the regulated activities of its portfolio companies.
Stewards of patient capital in regulated, high-barrier industries.
© 2026 Vantage Point Global, Corp. All rights reserved. Private & Confidential. Vantage Point Global, Corp. is a holding company. It does not conduct, direct, or control the licensed or regulated activities of its portfolio companies.